SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)

Plain-language summary

This study follows people with vascular Ehlers-Danlos syndrome (vEDS) confirmed by a disease-causing mutation in the COL3A1 gene, within a cohort. Adults and children with a genetically confirmed diagnosis may take part. It is a non-phase observational study that is currently active but not recruiting new participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Active, not recruiting

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Start date

12/5/2016

Estimated completion

1/1/2028

Countries

France

Related genes

Locations

• Angers, France
• Bordeaux, France
• Brest, France
• Caen, France
• Clermont-Ferrand, France
• Grenoble, France
• Lille, France
• Lyon, France
• Lyon, France
• Marseille, France
• Montpellier, France
• Nancy, France
• Nantes, France
• Paris, France
• Saint-Etienne, France
• Toulouse, France
• Tours, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

Patients eligible for inclusion in this study have to fulfil all of the following criteria:

* Patients (adults and children) with genetically-proven vEDS (presence of a pathogenic mutation at the COL3A1 gene);
* Patients (or his/her legal guardian) who does not oppose to his/her personal data collection.

There are no exclusion criteria for this study.